LSC Communications Inc
Change company Symbol lookup
Select an option...
LKSD LSC Communications Inc
GBT Global Blood Therapeutics Inc
FNMA Federal National Mortgage Association
FLWS 1-800-Flowers.Com Inc
EQH Axa Equitable Holdings Inc
ENTX Entera Bio Ltd
ELAN Elanco Animal Health Inc
DLX Deluxe Corp
BPMC Blueprint Medicines Corp
HZN Horizon Global Corp

Industrials : Commercial Services & Supplies | Small Cap ValueCompany profile

LSC Communications, Inc. focuses on traditional and digital print, print-related services and office products. The Company's segments are Print and Office Products. The Company, through its Print segment, provides a range of print product offerings, which include magazines, catalogs, retail inserts, books and directories. In addition to printed products, the Company also provides a number of print-related services, such as supply chain management, mail services, e-book formatting and distribution services. Its Print segment services over 3,000 customers, including publishers of magazines, books and directories, online retailers, catalogers, mass merchandisers and contract stationers. In its Office Products segment, the Company manufactures and sells a range of branded and private label products, primarily within the core categories, including filing products; note-taking products; binder products; tax and stock forms, and envelopes.

Closing Price
Day's Change
1.12 (13.51%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

UPDATE: Altria's credit rating cut 2 notches at S&P as a result of Juul, Cronos investments

10:02 am ET December 20, 2018 (MarketWatch)

Atria Group Inc. (MO) credit rating was slashed by two notches to BBB from A- at S&P Global Ratings, following the cigarette maker's recent announcements of a $12.8 billion investment ( in e-cigarette startup Juul Labs Inc. and a $1.8 billion investment ( in cannabis company Cronos Group Inc. (CRON.T). Altria's stock slipped 0.8% in premarket trade. That leaves Altria's credit rating just two notches above junk status. S&P said the rating outlook is stable. "We do not believe Juul or Cronos will provide significant near-term investment returns to Altria," S&P said in a statement. "Given Altria's track record of high shareholder returns, we do not expect the company to deleverage meaningfully from pro forma levels in the next few years." S&P said its downgrade also reflects growing uncertainty over how the Food and Drug Administration and state regulators could affect tobacco and non-tobacco product. Altria shares have dropped 28% year to date through Wednesday, while the S&P 500 has declined 6.2%.

-Tomi Kilgore; 415-439-6400;

(END) Dow Jones Newswires

December 20, 2018 10:02 ET (15:02 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.